Pillai Shiv
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.
Sci Immunol. 2023 Mar 31;8(81):eadg7327. doi: 10.1126/sciimmunol.adg7327. Epub 2023 Mar 24.
Repeated doses of mRNA vaccines for COVID-19 result in increased proportions of anti-spike antibodies of the IgG4 subclass, which are known to neutralize well and to form mixed immune complexes with IgG1 but, in a pure form, might be less effective than IgG1 or IgG3 antibodies in facilitating opsonization by phagocytes, complement fixation, and NK cell-dependent elimination of infected cells (see related Research Article by Irrgang .).
多次接种新冠病毒mRNA疫苗会导致IgG4亚类抗刺突抗体比例增加,已知这类抗体具有良好的中和能力,并能与IgG1形成混合免疫复合物,但单纯形式的IgG4在促进吞噬细胞调理作用、补体固定以及自然杀伤细胞依赖的感染细胞清除方面,可能不如IgG1或IgG3抗体有效(见伊尔冈的相关研究文章)。